Your browser doesn't support javascript.
loading
Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.
Mostaghel, Elahe A; Cho, Eunpi; Zhang, Ailin; Alyamani, Mohammad; Kaipainen, Arja; Green, Sean; Marck, Brett T; Sharifi, Nima; Wright, Jonathan L; Gulati, Roman; True, Lawrence D; Loda, Massimo; Matsumoto, Alvin M; Tamae, Daniel; Penning, Trevor N; Balk, Steven P; Kantoff, Phillip W; Nelson, Peter S; Taplin, Mary-Ellen; Montgomery, R Bruce.
  • Mostaghel EA; Fred Hutchinson Cancer Research Center, Seattle, Washington. emostagh@fhcrc.org.
  • Cho E; Palo Alto Medical Foundation, Palo Alto, California.
  • Zhang A; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Alyamani M; Lerner Research Institute, Glickman Urological and Kidney Institute, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Kaipainen A; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Green S; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Marck BT; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington.
  • Sharifi N; Lerner Research Institute, Glickman Urological and Kidney Institute, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Wright JL; University of Washington, Seattle, Washington.
  • Gulati R; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • True LD; University of Washington, Seattle, Washington.
  • Loda M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Matsumoto AM; Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington.
  • Tamae D; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Penning TN; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Balk SP; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Kantoff PW; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nelson PS; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Taplin ME; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Montgomery RB; University of Washington, Seattle, Washington.
Clin Cancer Res ; 23(16): 4592-4601, 2017 Aug 15.
Article en En | MEDLINE | ID: mdl-28389510
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Transportadores de Anión Orgánico / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Transportadores de Anión Orgánico / Neoplasias de la Próstata Resistentes a la Castración / Acetato de Abiraterona Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2017 Tipo del documento: Article